Real-life efficacy and safety of mepolizumab for eosinophilic granulomatosis with polyangiitis

Little is known about the efficacy and safety of the anti-interleukin 5 monoclonal antibody mepolizumab (MPZ) in patients with eosinophilic granulomatosis with polyangiitis (EGPA) in real-life. We thus evaluated disease activity, damage and disease-related complications in 14 patients with EGPA rece...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Giuseppe A. Ramirez, Adriana Cariddi, Silvia Noviello, Corrado Campochiaro, Valentina Canti, Luca Moroni, Mona-Rita Yacoub, Elena M. Baldissera, Enrica P. Bozzolo, Lorenzo Dagna
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2022-12-01
coleção:	Clinical Immunology Communications
Assuntos:	Eosinophilic granulomatosis with polyangiitis Mepolizumab Asthma Corticosteroids Infections
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2772613422000026
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!